The Lawrence J. Ellison Institute of USC Welcomes Jerry S.H. Lee, PhD as Chief Science and Innovation Officer.
The Lawrence J. Ellison Institute for Transformative Medicine of USC is thrilled to welcome Jerry S.H. Lee, PhD as its new Chief Science and Innovation Officer. Lee also joins Keck Medicine of USC as an Associate Professor of Clinical Medicine after serving as the Health Sciences Director of the National Cancer Institute at the National Institute of Health. He will augment the Ellison Institute’s ability to leverage technology, spark innovation, and drive research to reimagine and redefine cancer treatment, enhance health and transform lives.
The Urgency of Now: Dr. David Agus Interviews Former Vice President Joe Biden on the Cancer Moonshot
Vice President Biden reveals the new Biden Cancer Initiative, discusses the advances of the Cancer Moonshot, drug prices, and the importance of breaking down barriers in research with Dr. David Agus. Key moments in the talk include Vice President Biden discussing the importance of government funding, President Donald Trump, and whether he might consider running for office in 2020.
At a fundraising gala for the USC Center for Applied Molecular Medicine on May 11, the Oracle founder announced he is donating $200 million towards the opening of a new cancer research center, called the Lawrence J. Ellison Institute for Transformative Medicine of USC. The Institute will be the first of its kind, offering a multidisciplinary approach to cancer research, and creating a bold new model to fight this devastating disease.
Marc and Lynne Benioff give $20 million to support research and treatment innovations to fight cancer
Marc and Lynne Benioff announced their visionary $20 million gift toward the construction of the Lawrence J. Ellison Institute for Transformative Medicine of USC. “Cancer has deeply impacted our family and too many other families around the world,” Benioff said. “We truly believe that by empowering and funding institutions doing important cancer research we will be able to change the course of this disease.”